quinoxalines has been researched along with Experimental Mammary Neoplasms in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (10.00) | 18.2507 |
2000's | 5 (50.00) | 29.6817 |
2010's | 3 (30.00) | 24.3611 |
2020's | 1 (10.00) | 2.80 |
Authors | Studies |
---|---|
Hu, MH; Huang, Q; Jin, G; Wu, TY | 1 |
Cao, W; Kuang, H; Ma, J; Shi, L; Xu, L; Xu, Y; Zhang, P; Zhu, K | 1 |
Chai, EPZ; Ham, S; Krumeich, S; Lima, LG; Lobb, RJ; Möller, A; Muller, A; Wen, SW; Wiegmans, AP | 1 |
Kim, DK; Min, KN; Nam, JS; Park, CY; Park, SY; Sheen, YY; Son, JY | 1 |
Gali-Muhtasib, H; Geara, F; Haddadin, MJ; Haykal, J; Smith, CA | 1 |
Al-Hmaira, J; Gali-Muhtasib, H; Geara, F; Haddadin, MJ; Mona, AD; Sidani, M; Zaatari, G | 1 |
Aguirre, G; Arredondo, C; Basombrío, MA; Boiani, M; Cerecetto, H; Fernández, M; González, M; León, E; Pacheco, JP; Pintos, C; Raymondo, S | 1 |
Inoue, R; Kakiuchi, H; Makino, H; Nagao, M; Sugimura, T; Ushijima, T | 1 |
Futakuchi, M; Hirose, M; Kimoto, N; Kono, T; Lin, C; Nishibe, S; Shirai, T; Yamaguchi, T | 1 |
Hirose, M; Kawabe, M; Kimoto, N; Lin, C; Sano, M; Shirai, T | 1 |
10 other study(ies) available for quinoxalines and Experimental Mammary Neoplasms
Article | Year |
---|---|
New substituted quinoxalines inhibit triple-negative breast cancer by specifically downregulating the c-MYC transcription.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Female; G-Quadruplexes; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Promoter Regions, Genetic; Proto-Oncogene Proteins c-myc; Quinoxalines; Triple Negative Breast Neoplasms | 2019 |
Rational Design of a High-Performance Quinoxalinone-Based AIE Photosensitizer for Image-Guided Photodynamic Therapy.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Proliferation; Drug Design; Drug Screening Assays, Antitumor; Humans; Infrared Rays; Injections, Intravenous; Lasers; Mammary Neoplasms, Experimental; MCF-7 Cells; Mice; Mice, Nude; Molecular Structure; Particle Size; Photochemotherapy; Photosensitizing Agents; Quinoxalines; Rats; Rats, Sprague-Dawley; Surface Properties | 2020 |
Breast Cancer-Derived Exosomes Alter Macrophage Polarization
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Coculture Techniques; Cytokine Receptor gp130; Exosomes; Female; Hydrazines; Interleukin-6; Macrophage Activation; Macrophages; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C57BL; Primary Cell Culture; Quinoxalines; Signal Transduction; STAT3 Transcription Factor; Tumor Microenvironment | 2018 |
An novel inhibitor of TGF-β type I receptor, IN-1130, blocks breast cancer lung metastasis through inhibition of epithelial-mesenchymal transition.
Topics: Animals; Cell Line, Tumor; Cell Movement; Cell Nucleus; Drug Screening Assays, Antitumor; Epithelial-Mesenchymal Transition; Female; Humans; Imidazoles; Lung; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Neoplasm Invasiveness; Neoplasm Transplantation; Protein Serine-Threonine Kinases; Protein Transport; Quinoxalines; Receptor, Transforming Growth Factor-beta Type I; Receptors, Transforming Growth Factor beta; Transforming Growth Factor beta; Tumor Burden | 2014 |
The radiosensitizer 2-benzoyl-3-phenyl-6,7-dichloroquinoxaline 1,4-dioxide induces DNA damage in EMT-6 mammary carcinoma cells.
Topics: Adenocarcinoma; Apoptosis; Ataxia Telangiectasia Mutated Proteins; Blotting, Western; Cell Cycle; Cell Cycle Proteins; Cell Proliferation; Chromatin Immunoprecipitation; Combined Modality Therapy; Comet Assay; DNA Damage; DNA-Activated Protein Kinase; DNA-Binding Proteins; DNA, Neoplasm; Female; Flow Cytometry; Humans; Immunoenzyme Techniques; Mammary Neoplasms, Experimental; Nuclear Proteins; Protein Serine-Threonine Kinases; Quinoxalines; Radiation-Sensitizing Agents; Radiation, Ionizing; Reactive Oxygen Species; Tumor Cells, Cultured; Tumor Suppressor Proteins | 2009 |
Quinoxaline 1,4-dioxides are novel angiogenesis inhibitors that potentiate antitumor effects of ionizing radiation.
Topics: Adenocarcinoma; Angiogenesis Inhibitors; Animals; Blotting, Western; Carcinoma, Lewis Lung; Cell Hypoxia; Cell Survival; Collagen; Combined Modality Therapy; Drug Combinations; Female; Hypoxia-Inducible Factor 1, alpha Subunit; Laminin; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C57BL; Necrosis; Neovascularization, Pathologic; Proteoglycans; Quinoxalines; Radiation Tolerance; Radiation-Sensitizing Agents; Radiation, Ionizing; Reverse Transcriptase Polymerase Chain Reaction; Transcription Factors; Tumor Cells, Cultured; Tumor Stem Cell Assay; Vascular Endothelial Growth Factor A | 2004 |
Furoxan derivatives as cytotoxic agents: preliminary in vivo antitumoral activity studies.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Chemical Phenomena; Chemistry, Pharmaceutical; Chemistry, Physical; Female; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Oxadiazoles; Quinoxalines; Sarcoma, Experimental | 2006 |
Genetic alterations in HCA-induced tumors.
Topics: Animals; Carcinogens; Colonic Neoplasms; Diet; Female; Food; Genes, p53; Genes, ras; Humans; Imidazoles; Liver Neoplasms, Experimental; Mammary Neoplasms, Experimental; Mice; Mice, Inbred Strains; Mutagenesis; Mutagens; Neoplasms, Experimental; Point Mutation; Quinolines; Quinoxalines; Rats; Rats, Inbred F344; Stomach Neoplasms | 1995 |
Effects of arctiin on PhIP-induced mammary, colon and pancreatic carcinogenesis in female Sprague-Dawley rats and MeIQx-induced hepatocarcinogenesis in male F344 rats.
Topics: Animals; Biological Assay; Body Weight; Carcinogens; Carcinoma; Colonic Neoplasms; Diet; Drugs, Chinese Herbal; Female; Fibroadenoma; Furans; Glucosides; Glutathione Transferase; Imidazoles; Liver; Male; Mammary Neoplasms, Experimental; Pancreatic Neoplasms; Quinoxalines; Rats; Rats, Inbred F344; Rats, Sprague-Dawley; Time Factors | 2000 |
Modifying effects of propolis on MeIQx promotion of rat hepatocarcinogenesis and in a female rat two-stage carcinogenesis model after multiple carcinogen initiation.
Topics: Alkylating Agents; Animals; Carcinogens; Diethylnitrosamine; Disease Models, Animal; Ethanol; Female; Glutathione Transferase; Liver Neoplasms, Experimental; Male; Mammary Neoplasms, Experimental; Organ Size; Precancerous Conditions; Propolis; Quinoxalines; Random Allocation; Rats; Rats, Inbred F344; Water | 2000 |